Clinical trials
Observational Lymphoma, Follicular trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2010 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 5 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 23 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| China-Japan Friendship Hospital | 2 |
| Hospices Civils de Lyon | 2 |
| A.O.U. Città della Salute e della Scienza | 1 |
| Assuta Medical Center | 1 |
| Birgit Seelen-de Lang | 1 |
| Chinese University of Hong Kong | 1 |
| Decathlon SE | 1 |
| European Hematology Association - Lymphoma Group | 1 |
| Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 1 |
| Groupe Maladies hémorragiques de Bretagne | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Follicular | 23 |
| Lymphoma, B-Cell, Marginal Zone | 3 |
| Lymphoma, Mantle-Cell | 2 |
| Multiple Myeloma | 2 |
| Alopecia Areata | 1 |
| Anterior Cruciate Ligament Injuries | 1 |
| Chronic Limb-Threatening Ischemia | 1 |
| Composite Lymphoma | 1 |
| Craniocerebral Trauma | 1 |
| Cytokine Release Syndrome | 1 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.